“Regulatory risks are waning in the sector,†says Abhishek Sharma, pharma analyst at IIFL. Hereon, things are expected to move in positive direction for companies.
first published: Jul 11, 2016 09:04 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty reclaims 25,300, registers over 1% gain this week | Closing Bell
Live: Will Nifty bulls aim to break 25,250 after strong TCS Q2? | Opening Bell
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
You are already a Moneycontrol Pro user.